Related Experiment Video
Updated: Jul 10, 2026
06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Mycobacterium bovis BCG vertebral osteomyelitis after intravesical BCG therapy, diagnosed by PCR-based genomic
Takuya Nikaido1, Kei Ishibashi, Koji Otani
1Department of Orthopedics, Fukushima Medical University, Fukushima, Japan.
Journal of Clinical Microbiology
|October 26, 2007
Abstract:
We report a case of Mycobacterium bovis BCG vertebral osteomyelitis 1.8 years after intravesical BCG therapy for bladder cancer. We differentiated BCG from other Mycobacterium tuberculosis complex members by PCR analysis of deletion regions and started an appropriate chemotherapy regimen resulting in the remission of symptoms within 1 month.
